This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hampf, M. Articles by Bernhardt, R. Search for Related Content PubMed PubMed Citation Articles by Hampf, M. Articles by Bernhardt, R.

Unequal Crossing-Over between Aldosterone Synthase and 11ß-Hydroxylase Genes Causes Congenital Adrenal Hyperplasia

Max Delbrück Centrum für Molekulare Medizin (M.H.), 13125 Berlin, Germany; National Center for Natural Science and Technology, Institute of Biotechnology (N.T.N.D.), Cau Giay-Hanoi, Vietnam; National Institute of Pediatrics (N.T.H.), Vietnam; and Universität des Saarlandes, FB 8.8 Biochemie (R.B.), 66041 Saarbrücken, Germany

Address all correspondence and requests for reprints to: Dr. Rita Bernhardt, Universität des Saarlandes, FR 8.8 Biochemie, P.O. Box 15 11 50, D-66041 Saarbrucken, Germany. E-mail: ritabern{at}mx.uni-saarland.de

Abstract

Congenital adrenal hyperplasia is one of the most frequently inherited diseases. It is characterized by a severe decline in cortisol secretion, which results in a compensatory increase in ACTH and consequent adrenal growth (hyperplasia). Here we describe the first case of 11ß-hydroxylase deficiency that is caused by an unequal cross-over of the genes encoding aldosterone synthase (CYP11B2) and 11ß-hydroxylase (CYP11B1). CYP11B1 and CYP11B2 are located on chromosome 8q24 approximately 45 kb apart from each other. The investigated genetic recombination deleted the normal alleles of the two genes and created a chimeric fusion gene, which consists of the promotor and exons 1 through 4 of the aldosterone synthase gene plus intron 4 through exon 9 of the 11ß-hydroxylase gene. This recombination event subordinates any remaining 11ß-hydroxylase activity of the chimeric enzyme to the control mechanisms of CYP11B2, the expression of which is mainly regulated by angiotensin II and K⁺. Normally the 11ß-hydroxylase activity is controlled by ACTH. The existence of the CYP11B2/CYP11B1 chimera was discovered by means of a PCR method and was confirmed with a Southern blot. Furthermore, by applying a minigene expression method we demonstrated a point mutation in intron 3 (IVS3+16GT) of the patient’s second 11ß-hydroxylase allele that radically diminishes proper splicing of the pre-mRNA by giving rise to a new, highly preferred donor splice site.

This article has been cited by other articles:

				L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF]